We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
Read MoreHide Full Article
Walgreens Boots Alliance (WBA - Free Report) closed the most recent trading day at $21.45, moving -1.79% from the previous trading session. This move lagged the S&P 500's daily loss of 1.64%. Elsewhere, the Dow lost 1.08%, while the tech-heavy Nasdaq lost 1.82%.
Prior to today's trading, shares of the largest U.S. drugstore chain had lost 17.71% over the past month. This has lagged the Retail-Wholesale sector's loss of 0.11% and the S&P 500's gain of 0.89% in that time.
Investors will be hoping for strength from Walgreens Boots Alliance as it approaches its next earnings release, which is expected to be October 12, 2023. On that day, Walgreens Boots Alliance is projected to report earnings of $0.69 per share, which would represent a year-over-year decline of 13.75%. Our most recent consensus estimate is calling for quarterly revenue of $34.61 billion, up 6.67% from the year-ago period.
It is also important to note the recent changes to analyst estimates for Walgreens Boots Alliance. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.41% lower. Walgreens Boots Alliance is currently sporting a Zacks Rank of #4 (Sell).
Digging into valuation, Walgreens Boots Alliance currently has a Forward P/E ratio of 5.68. This represents a discount compared to its industry's average Forward P/E of 6.31.
It is also worth noting that WBA currently has a PEG ratio of 1.14. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. WBA's industry had an average PEG ratio of 1.25 as of yesterday's close.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This group has a Zacks Industry Rank of 195, putting it in the bottom 23% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
Walgreens Boots Alliance (WBA - Free Report) closed the most recent trading day at $21.45, moving -1.79% from the previous trading session. This move lagged the S&P 500's daily loss of 1.64%. Elsewhere, the Dow lost 1.08%, while the tech-heavy Nasdaq lost 1.82%.
Prior to today's trading, shares of the largest U.S. drugstore chain had lost 17.71% over the past month. This has lagged the Retail-Wholesale sector's loss of 0.11% and the S&P 500's gain of 0.89% in that time.
Investors will be hoping for strength from Walgreens Boots Alliance as it approaches its next earnings release, which is expected to be October 12, 2023. On that day, Walgreens Boots Alliance is projected to report earnings of $0.69 per share, which would represent a year-over-year decline of 13.75%. Our most recent consensus estimate is calling for quarterly revenue of $34.61 billion, up 6.67% from the year-ago period.
It is also important to note the recent changes to analyst estimates for Walgreens Boots Alliance. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.41% lower. Walgreens Boots Alliance is currently sporting a Zacks Rank of #4 (Sell).
Digging into valuation, Walgreens Boots Alliance currently has a Forward P/E ratio of 5.68. This represents a discount compared to its industry's average Forward P/E of 6.31.
It is also worth noting that WBA currently has a PEG ratio of 1.14. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. WBA's industry had an average PEG ratio of 1.25 as of yesterday's close.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This group has a Zacks Industry Rank of 195, putting it in the bottom 23% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.